Showing results (1731-1740 of 2,288) with videos related to

Sort By:
Pageof 229
HIV Medicine|February 25, 2025
Frequent hepatitis B surface antigen (HBsAg) clearance during tenofovir therapy in persons with HIV/hepatitis B virus coinfectionCharles Béguelin, Bernard Surial, Eveline Hofmann, et al.
HIV Medicine|February 17, 2025
Patients re-engaging with HIV care in Guatemala: Prioritizing CD4 counting and screening for histoplasmosis and tuberculosisNarda Medina, Ana Alastruey-Izquierdo, Oscar Bonilla, et al.
HIV Medicine|October 30, 2024
Effectiveness, safety, and patient-reported outcomes of emtricitabine/tenofovir alafenamide-based regimens for the treatment of HIV-1 infection: Final 24-month results from the prospective German TAFNES cohort studyChristoph Stephan, Christoph D Spinner, Ansgar Rieke, et al.
HIV Medicine|November 5, 2025
Prevalence of current substance and hazardous alcohol use among people with HIV and tuberculosis disease and its impact on tuberculosis treatment outcomes: A systematic reviewAnna Juul Christensen, Laura Risbjerg Omann, Jessica Carlsson, et al.
HIV Medicine|November 5, 2025
Effective and safe use of immune checkpoint inhibitors for non-small cell lung cancer in people living with HIVRebekka Mispelbaum, Tessa Hattenhauer, Christian Hoffmann, et al.
HIV Medicine|October 6, 2025
HIV prevention in London, UK, from 2017 to 2024: Outcomes, gaps and learningsGary Whitlock, Stephen Cole, Afshan Khurshid, et al.
HIV Medicine|October 15, 2025
A community and clinical collaboration to optimize HIV treatment and care for people with HIV in Australia-Solutions from the Beyond Undetectable symposiumMark O'Reilly, David Alain Wohl, Shauna Hall, et al.
HIV Medicine|October 10, 2025
Natural occurrence of drug resistance mutations to the HIV-1 capsid inhibitor lenacapavirA Weibull Wärnberg, R Ceña-Diez, A Sönnerborg, et al.
HIV Medicine|December 28, 2020
Transmitted HIV-1 drug resistance in a large international cohort using next-generation sequencing: results from the Strategic Timing of Antiretroviral Treatment (START) studyJ D Baxter, D Dunn, A Tostevin, et al.
HIV Medicine|December 28, 2020
A retrospective cohort study of early mortality among patients with HIV/TB co-infection in Shanghai municipalityT K Qi, J Chen, R F Zhang, et al.
Pageof 229